Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer

Conditions:   Multiple Endocrine Neoplasia;   Recurrent Thyroid Cancer;   Thyroid Gland Medullary CarcinomaInterventions:   Drug: sorafenib tosylate;   Other: pharmacological study;   Other: laboratory biomarker analysisSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials